Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7637798 | 0.77 | — | — | |
| SCHEMBL7640788 | 0.77 | — | — | |
| SCHEMBL35002 | 0.76 | TSHR (0.52) | TSHR | |
| SCHEMBL11860114 | 0.75 | — | — | |
| SCHEMBL9658416 | 0.75 | — | — | |
| SCHEMBL11668631 | 0.74 | TSHR (0.40) | TSHRTDP1 | |
| SCHEMBL16112394 | 0.74 | TSHR (0.40) | TSHRTDP1 | |
| SCHEMBL9775298 | 0.73 | TSHR (0.53) | TSHRTDP1 | |
| SCHEMBL28213123 | 0.73 | TSHR (0.53) | TSHRTDP1 | |
| SCHEMBL28905660 | 0.72 | TSHR (0.38) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 463 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117980359-A | Anaerobically curable compositions | 汉高股份有限及两合公司 | 2024-05-03 | — | — | CN | claimed |
| WO-2024046703-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2024-03-07 | — | — | WO | claimed |
| EP-4326789-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | Henkel AG & Co. KGaA (DE) | 2024-02-28 | — | — | EP | claimed |
| US-20240052219-A1 | ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2024-02-15 | — | — | US | claimed |
| US-11891512-B2 | Redox curable compositions and methods of manufacture thereof | HENKEL AG & CO. KGAA (DE) | 2024-02-06 | — | — | US | claimed |
| US-20230407150-A1 | ONE COMPONENT (1K) CURABLE ADHESIVE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2023-12-21 | — | — | US | claimed |
| CN-116964109-A | One-component (1K) curable adhesive composition | 汉高股份有限及两合公司 | 2023-10-27 | — | — | CN | claimed |
| EP-4061864-B1 | ONE COMPONENT (1K) ANAEROBIC CURABLE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2023-10-18 | — | — | EP | claimed |
| EP-3935109-B1 | ONE-PART ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2023-08-09 | — | — | EP | claimed |
| WO-2023110513-A1 | A CURABLE TWO-STEP AND TWO-PART ACRYLIC STRUCTURAL ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2023-06-22 | — | — | WO | claimed |
| WO-2014004315-A1 | ACCELERATOR/OXIDANT/PROTON SOURCE COMBINATIONS FOR TWO PART CURABLE COMPOSITIONS | Henkel US IP LLC (US) | 2014-01-03 | — | — | WO | claimed |
| WO-2014004309-A1 | ACCELERATORS FOR TWO PART CURABLE COMPOSITIONS | Henkel US IP LLC (US) | 2014-01-03 | — | — | WO | claimed |
| US-20140004366-A1 | ACCELERATOR/OXIDANT/PROTON SOURCE COMBINATIONS FOR TWO PART CURABLE COMPOSITIONS | HENKEL CORPORATION (US) | 2014-01-02 | — | — | US | claimed |
| US-20140004354-A1 | ACCELERATORS FOR TWO PART CURABLE COMPOSITIONS | HENKEL IRELAND LIMITED (DE) | 2014-01-02 | — | — | US | claimed |
| US-8481659-B2 | Cure accelerators for anaerobic curable compositions | HENKEL CORPORATION (US) | 2013-07-09 | — | — | US | claimed |
| US-20120157641-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2012-06-21 | — | — | US | claimed |
| EP-2424918-A2 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | Henkel Corporation (US) | 2012-03-07 | — | — | EP | claimed |
| WO-2010127055-A2 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | HENKEL CORPORATION (US) | 2010-11-04 | — | — | WO | claimed |
| US-5120779-A | Thermosetting blends having at least one highly and lesser unsaturated polymers, triazine compound, curing agent; ozone resistance, nonscorching | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1992-06-09 | — | — | US | claimed |
| EP-0171154-A1 | Cured rubber blend and process for the production thereof | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1986-02-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157641-A1 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | AHCY, AHCYL1, DNMT3L | TSHR 4869/4885TDP1 1853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.